Physician profile
John H Storey
NPI 1104914340
$2,188.05
in general payments reported to CMS, 2019-2025
15 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,190 · 2020: $31.07 · 2021: $12.74 · 2022: $74.26 · 2023: $497 · 2024: $105 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611 · Travel and Lodging: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.16 |
| Travel and Lodging | $268.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,246.02 | 2019-2022 | |
| Artivion, INC. | $280.65 | 2023 | Cardiac Non-Synergraft, Bioglue Surgical Adhesive |
| Atricure, INC. | $248.15 | 2023-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Gilead Sciences, INC. | $139.33 | 2023-2024 | Veklury |
| Zimmer Biomet Holdings, INC. | $46.43 | 2023 | Sternalock Blu System |
| Getinge USA Sales, LLC | $36.58 | 2025 | Cardioroot |
| Edwards Lifesciences Corporation | $36.28 | 2022-2023 | Sapien 3 Ultra Resilia |
| W. L. Gore & Associates, INC. | $31.86 | 2023 | Gore Excluder Iliac Branch Endoprosthesis |
| Biomerieux INC | $28.00 | 2025 | |
| Abiomed | $19.08 | 2023 | Impella |
| Pfizer INC. | $16.98 | 2025 | |
| Kls-Martin L.P. | $16.32 | 2023 | |
| Heartflow, INC. | $16.14 | 2022 | |
| Livanova USA, INC. | $14.53 | 2020 | |
| Medtronic Vascular, INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Storey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.